Drusen

Drusen are small yellow or white deposits that accumulate beneath the retina. They are one of the most common findings during a routine eye examination, especially in people over 50. While small drusen are a normal part of aging, larger or more numerous drusen are the hallmark of early age-related macular degeneration (AMD) and may indicate an increased risk of vision loss. Drusen beneath the retina should not be confused with optic disc drusen, which are calcified deposits within the optic nerve head—a completely different condition.

What Are Drusen?

Drusen form as part of the retina's natural waste-removal process. The retinal pigment epithelium (RPE)—a single layer of cells that supports the photoreceptors responsible for vision—constantly processes and recycles the waste products of the visual cycle. Over time, some of this debris is not fully cleared and accumulates as deposits between the RPE and Bruch's membrane, the thin barrier separating the retina from its underlying blood supply (the choroid). These deposits are drusen.

Composition

Drusen are composed of a complex mixture of:

• Lipids—cholesterol, phospholipids, and other fatty substances
• Proteins—complement factors, apolipoproteins, and inflammatory mediators
• Cellular debris—remnants of incompletely processed photoreceptor outer segments
• Minerals—calcium, zinc, and iron in varying amounts

The presence of complement factors and inflammatory proteins within drusen has led researchers to recognize that chronic, low-grade inflammation plays an important role in drusen formation and AMD progression.

Where Drusen Form

Drusen typically form in the macula—the central part of the retina responsible for sharp, detailed vision. The macula processes the highest volume of visual information and has the greatest metabolic demand, which may explain why waste products accumulate here preferentially. Drusen can also form outside the macula, but macular drusen are of greatest clinical concern because of their potential to affect central vision.

Types of Drusen

Not all drusen carry the same risk. Ophthalmologists classify drusen by their size, shape, and location, as each type has different implications for AMD risk and visual prognosis.

Small Hard Drusen

Small hard drusen are tiny (less than 63 micrometers in diameter, smaller than the width of a retinal vein at the optic disc), well-defined, round deposits with sharp borders. Under the microscope, they appear as discrete, dome-shaped mounds of material.

Key features:

• Extremely common—found in the majority of people over age 50
• Low risk—their presence alone does not constitute AMD
• Stable—rarely grow or change significantly over time
• No treatment needed—routine monitoring at standard intervals is sufficient

While small hard drusen are not considered a disease, they do indicate that the normal waste-clearance process is beginning to slow with age.

Large Soft Drusen

Large soft drusen are 125 micrometers or greater in diameter (about the width of a retinal vein), with poorly defined, indistinct borders. They may appear to merge with adjacent drusen, forming confluent deposits. On OCT, they appear as dome-shaped elevations of the RPE.

Key features:

• Higher risk—associated with early to intermediate AMD
• May grow and coalesce—individual drusen can merge into larger deposits
• Associated with RPE changes—overlying RPE may develop pigmentary abnormalities
• Progression risk—significantly increases the likelihood of developing dry AMD (geographic atrophy) or wet AMD (choroidal neovascularization)

Large soft drusen are one of the most important risk factors for AMD progression and are the primary finding that triggers closer monitoring and consideration of preventive supplements.

Reticular Pseudodrusen (Subretinal Drusenoid Deposits)

Reticular pseudodrusen are a distinct type of deposit located above the RPE, within the subretinal space, rather than below it like conventional drusen. They appear as a network of yellowish interlacing patterns, best seen on certain imaging modalities.

Key features:

• Different location—subretinal (between photoreceptors and RPE) rather than sub-RPE
• Best detected by multimodal imaging—fundus autofluorescence, infrared imaging, and OCT are more sensitive than standard fundus photography
• Higher risk of geographic atrophy—associated with a greater risk of progressing to dry AMD than conventional soft drusen
• Also associated with wet AMD risk—particularly type 3 (retinal angiomatous proliferation) neovascularization
• More common in women and individuals with certain genetic risk profiles

Recognition of reticular pseudodrusen has become increasingly important as they identify patients who may need more frequent monitoring.

Cuticular (Basal Laminar) Drusen

Cuticular drusen are numerous, small, round, uniform deposits that create a characteristic "starry-sky" or "stars-in-the-sky" appearance on fluorescein angiography. They are typically smaller than soft drusen but more numerous.

Key features:

• Distinctive angiographic pattern—each drusen appears as a bright hyperfluorescent dot, creating a striking punctate pattern
• May be associated with vitelliform changes—yellowish subretinal material that can reduce central vision
• Can occur at younger ages than typical AMD-related drusen
• Bilateral—usually affects both eyes symmetrically
• Variable risk—some patients remain stable for years while others develop complications

Drusen and Age-Related Macular Degeneration

The relationship between drusen and AMD is central to understanding this leading cause of vision loss in older adults. The Beckman Initiative classification system provides a standardized framework for categorizing AMD based on drusen characteristics.

Normal Aging vs Early AMD

The distinction between normal aging changes and early AMD is primarily determined by drusen size:

Classification	Drusen Size	Other Features	Risk Level
Normal aging	Small hard drusen only (<63 μm)	No pigment changes	Very low
Early AMD	Medium drusen (63-125 μm)	No pigment changes	Low to moderate
Intermediate AMD	Large drusen (>125 μm)	With or without pigment changes	Moderate to high
Late AMD	Any drusen	Geographic atrophy or neovascularization	Vision loss present

Early AMD

Early AMD is defined by the presence of medium-sized drusen (63 to 125 micrometers) without pigmentary abnormalities. At this stage:

• Vision is typically normal—patients usually have no symptoms
• Found incidentally—often discovered during a routine dilated fundus exam
• Low progression rate—the five-year risk of developing late AMD is approximately 1-3%
• No supplement treatment recommended—AREDS2 vitamins are not indicated at this stage according to current evidence

Intermediate AMD

Intermediate AMD is defined by at least one large drusen (125 micrometers or greater), multiple medium drusen, or any drusen accompanied by pigmentary changes (areas of increased or decreased pigmentation in the RPE).

• Vision may still be normal or near-normal—though some patients notice mild difficulty with contrast or adaptation to dim lighting
• Higher progression risk—approximately 18% five-year risk of developing late AMD in patients with large drusen and pigment changes in both eyes
• AREDS2 supplements recommended—clinical trial evidence supports supplementation at this stage (see Management section)
• Closer monitoring required—more frequent exams and home Amsler grid monitoring

Progression Risk

AMD can progress to two forms of late disease:

Dry AMD (Geographic Atrophy)—areas of RPE and photoreceptor cell death that gradually expand, causing permanent scotomas. Progression is typically slow but relentless. Newer therapies targeting complement activation may slow expansion.

Wet AMD (Choroidal Neovascularization)—abnormal new blood vessels grow from the choroid through Bruch's membrane and under or into the retina. These fragile vessels leak fluid and blood, causing rapid central vision loss. Treatment with anti-VEGF injections can stabilize and often improve vision if started promptly.

Risk Factors for Progression

Not all patients with drusen progress to late AMD. Factors that increase progression risk include:

• Drusen size—larger drusen confer higher risk
• Drusen number—more extensive drusen burden increases risk
• Confluent drusen—merged drusen are higher risk than isolated deposits
• Pigmentary changes—RPE hyperpigmentation or hypopigmentation alongside drusen significantly increases risk
• Genetics—variants in complement factor H (CFH) and ARMS2/HTRA1 genes are the strongest known genetic risk factors
• Smoking—the most significant modifiable risk factor, increasing AMD risk two- to fourfold
• Family history—first-degree relatives of AMD patients have higher risk
• Fellow eye status—if one eye has already developed late AMD, the other eye is at higher risk of progression

Drusen vs Optic Disc Drusen

Despite sharing the same name, retinal drusen and optic disc drusen are fundamentally different conditions that should not be confused.

Feature	Retinal Drusen	Optic Disc Drusen
Location	Under the retina (macula)	Within the optic nerve head
Composition	Lipids, proteins, cellular debris	Calcified deposits (mucopolysaccharides and calcium)
Appearance	Yellow dots/spots in the macula	Elevated, lumpy optic disc or buried (invisible on surface)
Age group	Primarily over 50	Any age, often found in children and young adults
Associated condition	Age-related macular degeneration	Pseudopapilledema; can cause visual field defects
Main concern	Central vision loss from AMD	Mimics optic disc edema; slow visual field loss
Prevalence	Very common (majority of elderly)	Found in approximately 1-2% of the population

If your doctor mentions "drusen," ask whether they are referring to macular (retinal) drusen or optic disc drusen, as the implications, monitoring, and management are entirely different.

Diagnosis

Drusen are diagnosed and monitored through several complementary imaging and examination techniques.

Dilated Fundus Exam

A dilated fundoscopic exam is usually how drusen are first discovered. After dilating your pupils with eye drops, your doctor examines the retina directly using a slit lamp with a magnifying lens or an ophthalmoscope. Drusen appear as yellow-white deposits in the macula. The doctor notes their size, number, distribution, and any associated pigmentary changes.

Optical Coherence Tomography (OCT)

OCT has become indispensable for evaluating and monitoring drusen. This non-invasive imaging technology provides micron-resolution cross-sectional images of the retina, allowing your doctor to:

• Visualize individual drusen—their size, shape, and precise location relative to the RPE and Bruch's membrane
• Detect subretinal fluid—an early sign of wet AMD conversion that may not be visible on clinical exam
• Identify reticular pseudodrusen—which appear above the RPE as hyperreflective deposits
• Measure RPE and outer retinal changes—thinning of the photoreceptor layer overlying drusen suggests early atrophy
• Track changes over time—serial OCT scans can detect drusen growth, new drusen formation, or early signs of geographic atrophy or neovascularization

Fundus Photography

Fundus photography provides high-resolution color photographs of the retina that serve as a permanent record. Serial photographs taken months or years apart allow direct visual comparison to detect:

• New drusen formation
• Growth of existing drusen
• Development of pigmentary changes
• Early geographic atrophy

Many practices now use widefield photography to capture the central and peripheral retina in a single image.

Fundus Autofluorescence (FAF)

Fundus autofluorescence imaging detects the natural fluorescence of lipofuscin, a waste product that accumulates in RPE cells. This technique is particularly valuable for:

• Detecting RPE stress—increased autofluorescence around drusen indicates RPE cells under metabolic strain, which may predict progression
• Identifying geographic atrophy—areas of RPE death appear as dark (hypoautofluorescent) patches
• Visualizing reticular pseudodrusen—which appear as a characteristic reticular hypofluorescent pattern
• Monitoring atrophy expansion—serial FAF imaging tracks how quickly geographic atrophy grows

Fluorescein Angiography

Fluorescein angiography involves injecting a fluorescent dye into a vein and photographing the retinal blood vessels as the dye passes through. It is not routinely performed for drusen monitoring but is indicated when:

• Wet AMD is suspected—new symptoms of distortion, dark spot, or decreased vision in a patient with known drusen
• Cuticular drusen are suspected—produces the characteristic "starry-sky" pattern
• Differentiating types of neovascularization—helps guide treatment decisions

Management

Management of drusen depends on the stage of AMD and individual risk factors. The goal is to preserve vision by slowing or preventing progression to late AMD.

Monitoring Schedule

The frequency of follow-up examinations is based on your risk level:

• Small hard drusen only (normal aging)—routine comprehensive eye exam every 1-2 years
• Early AMD (medium drusen)—annual dilated exam with OCT
• Intermediate AMD (large drusen or pigment changes)—every 6-12 months with OCT, fundus photography, and home Amsler grid monitoring
• Late AMD in one eye—close monitoring of the fellow eye, often every 3-6 months

AREDS2 Supplements

The Age-Related Eye Disease Study 2 (AREDS2) demonstrated that a specific combination of nutritional supplements reduces the risk of progression from intermediate to late AMD by approximately 25%. The AREDS2 formula contains:

• Vitamin C—500 mg
• Vitamin E—400 IU
• Zinc—80 mg (with 2 mg copper to prevent zinc-related deficiency)
• Lutein—10 mg
• Zeaxanthin—2 mg

Important notes about AREDS2 supplements:

• Recommended for intermediate AMD or late AMD in one eye—not for early AMD or normal aging drusen
• Do not cure AMD—they reduce risk of progression but do not eliminate it
• Beta-carotene was removed in the AREDS2 formula due to increased lung cancer risk in smokers—lutein and zeaxanthin replaced it
• Consult your doctor before starting—zinc doses may need adjustment, and interactions with other medications should be reviewed

Lifestyle Modifications

Several lifestyle factors significantly influence AMD risk and progression:

• Stop smoking—the single most impactful modifiable change; smoking dramatically increases AMD risk and progression
• Healthy diet—dark leafy greens (spinach, kale), colorful fruits and vegetables, and fish rich in omega-3 fatty acids are associated with lower AMD risk
• UV protection—wear sunglasses with UV-A and UV-B protection outdoors
• Regular exercise—cardiovascular fitness is associated with reduced AMD risk
• Blood pressure and cholesterol management—cardiovascular health supports retinal health
• Maintain healthy weight—obesity is associated with increased AMD progression

Amsler Grid Home Monitoring

The Amsler grid is a simple at-home tool for detecting early changes in central vision. Patients at risk for wet AMD conversion should check the Amsler grid regularly—ideally daily, testing each eye separately.

When Drusen Become Concerning

While many people with drusen will never develop vision-threatening AMD, certain signs should prompt you to contact your eye doctor:

Signs of progression requiring evaluation:

• Any new distortion or waviness in your vision
• A new dark or blurry area in your central vision
• Difficulty reading or recognizing faces that is new or worsening
• Colors appearing less vivid or washed out
• Increased difficulty adapting from bright to dim environments

Signs your doctor watches for:

• Growth of existing drusen or appearance of new large drusen
• Development of pigmentary changes alongside drusen
• Subretinal fluid detected on OCT
• Geographic atrophy developing adjacent to drusen
• Any sign of choroidal neovascularization

Regular examinations are essential because early wet AMD and geographic atrophy can be detected before you notice symptoms, and earlier intervention leads to better outcomes.

Frequently Asked Questions

Are drusen dangerous?

Small hard drusen are not dangerous—they are a normal part of aging found in most people over 50. Large soft drusen, numerous drusen, and drusen with pigmentary changes carry increased risk for AMD progression and potential vision loss. Your ophthalmologist can assess your specific risk based on the type, size, and number of drusen along with other factors like genetics and smoking history.

Can drusen go away?

Drusen can change over time. Small drusen may occasionally disappear, and large drusen may regress. However, the disappearance of large drusen is not always a good sign—it can indicate the development of geographic atrophy (RPE death) in that area, which is a form of late AMD. This is why ongoing monitoring with OCT and other imaging is more important than simply tracking whether drusen are present.

Should I take vitamins for drusen?

The AREDS2 supplement formula is recommended only for patients with intermediate AMD (large drusen and/or pigmentary changes) or those with late AMD in one eye. If you have only small hard drusen or early AMD, current evidence does not support taking AREDS2 supplements specifically for your eyes. A healthy diet rich in leafy greens, colorful fruits and vegetables, and omega-3 fatty acids is recommended for everyone. Always discuss supplements with your doctor, as high-dose zinc and other components may interact with medications.

Will I go blind from drusen?

The vast majority of people with drusen will not go blind. Even those who develop late AMD typically retain peripheral vision—central vision may be affected, but total blindness is rare. With modern treatments, particularly anti-VEGF injections for wet AMD, many patients maintain functional reading vision. The best way to protect your vision is through regular monitoring, prompt reporting of new symptoms, and lifestyle modifications such as quitting smoking.

How often do I need eye exams if I have drusen?

The frequency depends on your risk level. If you have only small hard drusen with no other risk factors, a comprehensive eye exam every 1-2 years is typically sufficient. If you have medium or large drusen, pigmentary changes, or other risk factors, your doctor may recommend exams every 6 to 12 months with OCT imaging. If you have late AMD in one eye, the fellow eye may need monitoring every 3 to 6 months. Your ophthalmologist will recommend a schedule based on your individual risk profile.

References